Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multi-Center, Open Label Long-Term Extension Trial To Assess The Safety Of Oral Uk-390,957 Administered As Required In Adult Men With Premature Ejaculation

NCT00219609 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00219609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00219609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multi-Center, Open Label Long-Term Extension Trial To Assess The Safety Of Oral Uk-390,957 Administered As Required In Adult Men With Premature Ejaculation
Lead sponsor
Pfizer
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2005
Completion date
March 31, 2006
Enrollment
1,058
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

ejaculation